AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 2 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,366,350 | -17.6% | 91,091 | -15.3% | 0.19% | -9.5% |
Q2 2023 | $7,727,321 | +15.7% | 107,533 | -0.7% | 0.21% | +8.8% |
Q1 2023 | $6,678,772 | +89740.9% | 108,281 | +12.3% | 0.19% | -17.2% |
Q4 2022 | $7,434 | -99.8% | 96,386 | -9.8% | 0.23% | +51.3% |
Q3 2022 | $4,767,000 | -11.9% | 106,839 | -24.4% | 0.15% | -5.5% |
Q2 2022 | $5,411,000 | -21.1% | 141,284 | -14.7% | 0.16% | +0.6% |
Q1 2022 | $6,857,000 | +52.1% | 165,656 | +38.9% | 0.16% | +80.0% |
Q4 2021 | $4,507,000 | +18.0% | 119,298 | +2.9% | 0.09% | +13.9% |
Q3 2021 | $3,821,000 | -59.2% | 115,939 | -16.6% | 0.08% | -53.0% |
Q2 2021 | $9,373,000 | +28.9% | 138,935 | +8.2% | 0.17% | +24.4% |
Q1 2021 | $7,270,000 | -39.0% | 128,405 | -12.2% | 0.14% | -40.5% |
Q4 2020 | $11,921,000 | – | 146,325 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |